RAINBOWFISH Study in NEJM Highlights Risdiplam’s Impact in Presymptomatic SMA, Importance of Newborn Screening
Phase 3 study demonstrates risdiplam's effectiveness in treating presymptomatic spinal muscular atrophy, showing improved outcomes for infants identified through newborn screening.